We detected similar alterations in our PD iPSC-DA neurons and further showed that pharmacological mTOR inhibition restores TFEB activity and enhances autophagyic clearance, thus reducing both ER stress levels and toxic α-synuclein accumulation. Here, MTOR is linked to Parkinson disease.